Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment guidelines for HIV-associated wasting.

P M Nemechek1, B Polsky, M S Gottlieb

  • 1Nemechek Health Renewal, Prairie Village, Kan. 66208, USA.

Mayo Clinic Proceedings
|April 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lymphoepithelioma-like gastric carcinoma: an unusual consequence of Epstein-Barr virus infection in an HIV-infected woman.

International journal of STD & AIDS·2013
Same author

Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
Same author

Multiple skin nodules in a recreational gardener from New York.

Clinical and experimental dermatology·2011
Same author

Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania infantum with posaconazole.

Antimicrobial agents and chemotherapy·2011
Same author

A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS.

Neurology·2007
Same author

Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2003
Same journal

Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

Mayo Clinic proceedings·2026
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
See all related articles

Human immunodeficiency virus (HIV)-associated wasting in acquired immunodeficiency syndrome (AIDS) patients can be treated with nutritional counseling and medications. Mammalian-derived growth hormone (rhGH[m]) shows promise for sustained weight and body cell mass gains.

Area of Science:

  • Immunology
  • Nutrition Science
  • Endocrinology

Background:

  • Acquired immunodeficiency syndrome (AIDS) patients frequently experience weight loss due to decreased body cell mass (BCM).
  • Causes of HIV-associated wasting include anorexia, malabsorption, and metabolic changes impacting nutrient utilization.
  • Gastrointestinal issues, opportunistic infections, and direct HIV effects contribute to malabsorption and diarrhea.

Purpose of the Study:

  • To review the causes and nutritional assessment of HIV-associated wasting.
  • To discuss various treatment strategies for weight loss in AIDS patients.
  • To evaluate the efficacy of different interventions, including growth hormone therapy.

Main Methods:

  • Literature review of studies on HIV-associated wasting.

Related Experiment Videos

  • Analysis of nutritional assessment components for AIDS patients.
  • Evaluation of pharmacological and nutritional interventions.

    • Main Results:

    • Nutritional counseling and addressing opportunistic infections are initial steps, but do not always reverse wasting.
    • Total parenteral nutrition, dronabinol, megestrol acetate, and testosterone replacement have varying effects on weight and BCM.
    • Mammalian-derived human growth hormone (rhGH[m]) demonstrated sustained weight and BCM gains in clinical trials.

    Conclusions:

    • HIV-associated wasting requires a comprehensive approach, including nutritional support and targeted therapies.
    • While some treatments promote weight gain, rhGH[m] offers sustained gains in BCM for refractory cases.
    • Effective management of wasting can improve survival, functioning, and quality of life for AIDS patients.